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The msaABCR Operon Regulates
Persister Formation by Modulating
Energy Metabolism in
Staphylococcus aureus
Shanti Pandey, Gyan S. Sahukhal* and Mohamed O. Elasri
Center for Molecular and Cellular Biosciences, The University of Southern Mississippi, Hattiesburg, MS, United States
Staphylococcus aureus is a major human pathogen that causes chronic, systemic
infections, and the recalcitrance of these infections is mainly due to the presence of
persister cells, which are a bacterial subpopulation that exhibits extreme, yet transient,
antibiotic tolerance accompanied by a transient halt in growth. However, upon cessation
of antibiotic treatment, a resumption in growth of persister cells causes recurrence of
infections and treatment failure. Previously, we reported the involvement of msaABCR
in several important staphylococcal phenotypes, including the formation of persister
cells. Additionally, observations of the regulation of several metabolic genes by the
msaABCR operon in transcriptomics and proteomics analyses have suggested its role
in the metabolic activities of S. aureus. Given the importance of metabolism in persister
formation as our starting point, in this study we demonstrated how the msaABCR
operon regulates energy metabolism and subsequent antibiotic tolerance. We showed
that deletion of the msaABCR operon results in increased tricarboxylic acid (TCA) cycle
activity, accompanied by increased cellular ATP content and higher NADH content in
S. aureus cells. We also showed that msaABCR (through MsaB) represses the ccpE
and ndh2 genes, thereby regulating TCA cycle activity and the generation of membrane
potential, respectively. Together, the observations from this study led to the conclusion
that msaABCR operon deletion induces a metabolically hyperactive state, leading to
decreased persister formation in S. aureus.
Keywords: Staphylococcus aureus, msaABCR, persister cells, ATP, membrane potential
INTRODUCTION
Staphylococcus aureus is a prominent human pathogen that causes systemic diseases, including
infective endocarditis, osteomyelitis, bacteremia, and pneumonia (Lowy, 1998). Often chronic in
nature, these infections are typically caused by device-associated biofilms that harbor persister
cells (Lafleur et al., 2010; Lewis, 2010; Conlon et al., 2015). Persister cells are a distinct phenotypic
variant in the bacterial population that exhibits transient, yet extreme, antibiotic tolerance without
undergoing any genetic modification (Hobby, 1942; Bigger, 1944; Lewis, 2010). In the absence of
antibiotic resistance, antibiotic-tolerant persister cells are believed to be largely responsible for the
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recalcitrance of bacterial infections and treatment failures
(Conlon, 2014), thereby having high clinical significance. Indeed,
the clinical relevance of S. aureus persister cells is now
increasingly understood, as evidenced by their reported presence
in recurring infections (Becker et al., 2014; Conlon, 2014).
For instance, cases of bacteremia relapse, including recurring
infections in endocarditis and in lung-transplanted patients, were
caused by vancomycin-, linezolid-, and daptomycin-susceptible
S. aureus (Ruiz et al., 2002; Corne et al., 2005; Welsh et al., 2011).
Moreover, the clinical significance of S. aureus persister cells was
also demonstrated in a chronic mouse wound infection model,
in which these cells could not be eradicated by conventional
drugs (Allison et al., 2011; Conlon et al., 2013). Indeed, persister
cells are ubiquitous and have been studied in multiple bacterial
species (Van den Bergh et al., 2017). However, the mechanism
of persister formation has been a puzzling problem, particularly
due to the transience of these cells and their small population
size. Nonetheless, studies have so far demonstrated an association
between the depletion of intracellular ATP and the formation of
persister cells in major bacterial pathogens, including S. aureus,
Escherichia coli, and Pseudomonas aeruginosa (Conlon et al.,
2016; Shan et al., 2017; Cameron et al., 2018).
In recent years, an increasing number of studies have sought
to understand the mechanism of persister formation, which is
dependent on the metabolic activities of bacterial cells. Several
studies have examined the contribution of metabolic genes and
cellular ATP levels in the formation of S. aureus persister cells.
For instance, Yee et al. (2015) identified the involvement of
purine genes in persister cell formation in the presence of
rifampicin. Likewise, Wang et al. (2015) showed that a mutant
of succinate dehydrogenase (encoded by sdhA/B) is defective in
formation of persister cells against an antibiotic (levofloxacin),
heat, and oxidative stresses. Similarly, inactivation of phoU
causes deficiency in the persister population due to increased
metabolic activity (Shang et al., 2020). Recently, inactivation
of tricarboxylic acid (TCA) cycle genes was shown to form
drastically increased numbers of persister cells due to reduced
ATP and membrane potential, suggesting the role of metabolism
in persister formation (Wang et al., 2018; Zalis et al., 2019).
This association was also evidenced in polymicrobial cultures
in which S. aureus displayed increased antibiotic tolerance,
accompanied by reduced membrane potential and intracellular
ATP concentration (Nabb et al., 2019). The reduced ATP level
associated with increased persister formation was also observed
in inactivation of carbamoyl phosphate synthetase (encoded by
carB) in the major pathogens S. aureus, E. coli, and P. aeruginosa
(Cameron et al., 2018). In general, it appears that the conditions
that reduce intracellular ATP and membrane potential, as well as
cease transcription or translation, dramatically increase antibiotic
tolerance in bacteria (Wood et al., 2013; Conlon et al., 2016;
Shan et al., 2017). Together, these observations strongly suggest
that the cellular metabolism and subsequent energy state of cells
determine their switch to the persister phenotype.
Previously, we identified and characterized the msaABCR
operon, constituting four genes (msaA, msaB, msaC, and anti-
sense msaR) and regulated by two non-coding RNAs msaC
and msaR (Sahukhal and Elasri, 2014). Further, we identified
MsaB as a dual transcriptional regulator that functions as an
activator as well as repressor to regulate its target genes (Batte
et al., 2018; Pandey et al., 2019). In addition, Caballero and
coworkers (Caballero et al., 2018) showed MsaB to be an RNA
chaperone binding to 213 mRNAs, suggesting that MsaB is a
global regulator. We have found a positive regulatory role for
the msaABCR operon in biofilm development (Sahukhal et al.,
2015), capsule production (Batte et al., 2018), antibiotic resistance
(Bibek et al., 2019), antibiotic tolerance (Sahukhal et al., 2017),
response to oxidative stress, and intracellular survival (Pandey
et al., 2019). Moreover, in a recent study, we observed that an
msaABCR operon mutant is attenuated in rat models of acute and
chronic implant-associated osteomyelitis (Sahukhal et al., 2020).
Deletion of the msaABCR operon in the methicillin-
resistant S. aureus (MRSA) strain USA300 LAC and the
vancomycin-intermediate S. aureus (VISA) strain Mu50
formed fewer persister cells against several clinically relevant
antibiotics (vancomycin, daptomycin, rifampicin, linezolid, and
gentamicin). In transcriptomics and proteomics studies, we
observed regulation of several metabolic genes by the msaABCR
operon (Sahukhal et al., 2017). Together, these observations
suggest a causal link between regulation of metabolic activities
and formation of persister cells by the msaABCR operon. In
the present study, we attempted to elucidate the role of the
msaABCR operon in the regulation of metabolism and persister
cell formation during the late stages of S. aureus growth.
MATERIALS AND METHODS
Bacterial Strains, Culture Conditions,
and Transposon Mutant Construction
Methicillin-resistant S. aureus USA300 LAC, isogenic
msaABCR operon deletion mutant (MmsaABCR), and
MmsaABCR + pCN34.msaABCR (Complementation) strains
were used. TheMmsaABCR andMmsaABCR+ pCN34.msaABCR
strains were generated as previously described (Sahukhal and
Elasri, 2014). Briefly, the MmsaABCR strain was generated by
using pKOR1 allelic gene replacement method (Sahukhal and
Elasri, 2014). The MmsaABCR + pCN34.msaABCR complement
strain was generated by inserting plasmid pCN34 that contained
functional copy msaABCR operon gene in MmsaABCR strain
(Sahukhal and Elasri, 2014). Bacterial pre-cultures were prepared
by inoculating cells from frozen culture into 5 ml of freshly
prepared tryptic soy broth (TSB) (Becton, Dickinson and
Company, Sparks, MD, United States) or chemically defined
medium (CDM), as previously described (Batte et al., 2018).
All cultures were incubated at 37◦C with continuous shaking
at 225 rpm. All the stationary-phase cultures were grown for
24 h, unless otherwise stated. All the transposon mutants used
in this study were generated in the USA300 LAC background
as previously described (Batte et al., 2018; Pandey et al.,
2019). Briefly, a plasmid-cured derivative of LAC strain JE2
containing the transposon mutation within the coding regions
of the corresponding genes was obtained from the Network on
Antimicrobial Resistance in the S. aureus (NARSA) collection
(BEI Resources). The mutation was then transduced into
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the USA300 LAC strain by generalized transduction using
bacteriophage ϕ11. The transduction of the mutation into the
recipient strains was confirmed by amplifying the beginning and
end of the open reading frame of the corresponding genes, as
previously described (Fey et al., 2013; Batte et al., 2018; Pandey
et al., 2019). The detail information about the strains used in this
study is listed in Supplementary Table 1.
Measurement of ATP
Intracellular ATP content was measured using the BacTiter-
GloTM kit according to the manufacturer’s instruction. Briefly,
cells grown to the required phase were adjusted to an OD600
nm of 0.025 in 1 ml of TSB, from which 50 µl were dispensed
into wells of an opaque 96-well plate, followed by the addition of
an equal volume of BacTiter-GloTM Reagent. The luminescence
was measured at OD560 nm after 5 min of incubation at
room temperature.
RNA Extraction, Reverse Transcription,
and qRT-PCR
Aliquots of 500 µl from the required growth cultures were
treated with equal volumes of RNAprotect bacterial reagent
(Qiagen, Valencia, CA, United States) for 5 min at room
temperature. Total RNA was extracted using the Qiagen RNeasy
kit (Qiagen), and the quality and concentration of the extracted
RNA were analyzed using a NanoDrop spectrophotometer
(Thermo Scientific). Reverse transcription was performed with
the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules,
CA, United States) using 1 µg of the total RNA isolated according
to the manufacturer’s instruction. Next, qRT-PCR was performed
using SYBR Green supermix (Bio-Rad), and the relative fold
change in gene expression was calculated using gyrB as an
endogenous control gene. The data represent the results from
three independent experiments. All primers used in qRT-PCR are
listed in Supplementary Table 2.
Measurement of NAD+/NADH Content
Overnight cultures were diluted to an OD600 of 0.05 and grown
until late exponential phase (OD600 of 4.0). Cells were harvested
and washed twice with ice-cold phosphate-buffered saline (PBS),
and NADH levels were measured according to the manufacturer’s
instructions (NAD+/NADH quantitation kit, Sigma-Aldrich).
Values represent the absolute concentrations of NAD+ and
NADH per µg of protein.
Persister Assays
Frozen S. aureus cells were inoculated in fresh TSB and grown
for ∼3 h. These pre-cultures were normalized to an OD600 nm
of 0.05 in 5 ml of TSB at a flask-to-medium ratio of 10:1 and
incubated at 37◦C until the required growth phase. Persister
assays in late exponential phase were performed when the culture
OD600 reached 4.0 (after 3.5–4 h growth), whereas the culture
was grown for 24 h to reach stationary phase. When the cells
reached the required growth phase, 100-µl aliquots were diluted
in PBS and plated for the initial colony-forming unit (CFU)
counting, whereas 3 ml of the culture was transferred to a 50-ml
tube and was individually challenged with gentamicin (20 µg/ml,
20×MIC), vancomycin (62.5 µg/ml, 100×MIC), ciprofloxacin
(250 µg/ml, 100 ×MIC), or tobramycin (20 µg/ml, 20 ×MIC).
The cultures were then incubated to determine the persister
count. At the designated time post exposure, 100 µl of culture was
removed, washed with PBS, diluted, and plated for CFU counting.
For the persister assay of biofilms, a previously described
in vitro catheter model of biofilm formation was implemented
(Weiss et al., 2009; Sahukhal et al., 2017). Briefly, 1-cm-long
sterile catheters (Becton Dickinson Infusion Therapy System
Inc., Sandy, UT, United States) were incubated with 20%
human plasma (Sigma-Aldrich, Saint Louis, MO, United States)
overnight in 24-well microtiter plates. After plasma coating, the
catheters were incubated with S. aureus cells (OD600 of 0.05)
in biofilm medium (TSB + 0.5% glucose + 3% NaCl) for 24 h
with continuous shaking. After incubation, the catheters were
removed, washed gently with PBS to remove the non-adherent
S. aureus cells, and sonicated for initial CFU counting. The
remaining catheters were treated with tobramycin (20 µg/ml,
20 × MIC) and further incubated at 37◦C. Each day after
treatment, the catheters (n = 3) were recovered, and the spent
medium was replaced with fresh biofilm medium (500 µl)
with 20 µg/ml tobramycin. The catheters were gently rinsed
in PBS to remove any non-adherent bacteria, placed in glass
tubes, and sonicated to recover the adherent S. aureus cells.
The recovered CFUs were counted for all three catheters. This
procedure was continued for 4 days. All experiments were
performed in triplicate and repeated twice. For the persister
cell count in the presence of arsenate and carbonyl cyanide
m-chlorophenyl hydrazone (CCCP), stationary-phase cells were
challenged with arsenate (1 mM) and different concentrations
of CCCP (0.001–10 µM) for 30 min prior to the addition of
gentamicin. At 24 h post exposure, the cells were harvested,
washed, and plated for CFU counting. All experiments were
performed with at least three biological replicates. MIC values for
the antibiotics are listed in Supplementary Table 3.
Measurement of Membrane Potential
Membrane potential was assessed using the BacLightTM
Bacterial Membrane Potential kit (Life Technologies, Carlsbad,
CA, United States). Stationary-phase cells were washed and
resuspended with 0.5 ml of filtered PBS (2 × 107 cells). Next,
16.6 µl of the fluorescent membrane potential indicator dye 3,
3′-diethyloxacarbocyanine iodide (DiOC2(3)) was added and
incubated at room temperature for 30 min. The fluorescent
signals of 100,000 cells were recorded using a Fortressa flow
cytometer (BD Biosciences, San Jose, CA, United States).
Negative control cells were incubated with 10 µM CCCP
for 30 min prior to adding DiOC2(3). The ratio between
red fluorescence (PE-A) and green fluorescence (FITC) was
calculated and analyzed with FlowJo v10 software.
Expression and Purification of MsaB
Protein
The MsaB protein was expressed in MmsaABCR of USA300 LAC
strain as previously described (Pandey et al., 2019). Expression
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of protein (MsaB-His) was induced with the addition of 10 µM
cadmium chloride (CdCl2) at the exponential phase (OD600
of 0.5–0.7) followed by incubation further for ∼4 h with
continuous shaking. After 4 h of induction the cells were pelleted,
resuspended in PBS (pH 7.4) with a protease inhibitor cocktail,
and then lysed by bead beating and sonication. The cell lysate
was then centrifuged at 10,000 × g for 30 min to remove the cell
debris. The 6× His-MsaB fusion protein was purified from the
clear lysate using nickel column (HisPur Ni-nitrilotriacetic acid
[Ni-NTA] resin; Thermo Scientific) method.
Electrophoretic Mobility Shift Assay
(EMSA)
Electrophoretic mobility shift assays (EMSAs) were performed
using the LightShiftTM optimization and control kit (Thermo
Scientific) according to the manufacturer’s protocol and as
previously described (Batte et al., 2016; Pandey et al., 2019).
Briefly, the binding reaction mixture was prepared with ultrapure
water containing 1× binding buffer, 50 ng poly (dI-dC),
2.5% (v/v) glycerol, 0.05% (v/v) NP-40, and 5 mM MgCl2.
Biotin-labeled single-stranded DNA (ssDNA) upstream of the
transcription initiation site of the ndh2 gene and double-
stranded DNA (dsDNA) of the ccpE gene in the appropriate
concentrations were incubated with increasing concentrations of
purified recombinant MsaB–His protein in the binding reaction
buffer and unlabeled specific probe when required. The mixture
was then incubated at room temperature for 25 min and subjected
to electrophoresis at 100 V for 1 h in a pre-run 5% Tris-
borate EDTA (TBE) gel. The samples were then transferred
to a nylon membrane, incubated for 45 min in the cold,
crosslinked, and processed for the detection of samples. The
protein–DNA complexes in the gel were then visualized using
the Chemiluminescent EMSA kit (Thermo Scientific) according
to the manufacturer’s protocol and imaged with a ChemiDoc
system (Bio-Rad). The probes used for EMSA studies are listed
in Supplementary Table 2.
Gentamicin Uptake Assay
Gentamicin–Texas Red conjugate (Gent: TR) was prepared as
previously described (Dai et al., 2006) with slight modifications.
Briefly, 440 µl of 50 mg gentamicin sulfate ml−1 was mixed
with 60 µl of 2 mg amine-reactive Texas Red-X succinimidyl
ester (Invitrogen) ml−1 in anhydrous N, N-dimethylformamide.
The mixture was gently rotated for 3 days at 4◦C to produce
an approximately 30: 1 molar ratio (∼10 mM gentamicin and
0.3 mM Texas Red reagent) of Gen: TR. Next, 100 µl of the
Gen: TR was added to the stationary phase cells (2 × 107),
washed, and resuspended in 2 ml PBS for 3 h at 37◦C with
continuous rotation. After incubation, the cells were washed
twice, resuspended in 500 µl PBS, and evaluated by flow
cytometry with excitation/emission maxima at 595/615 nm.
Statistical Analyses
All data were analyzed using GraphPad Prism (version 8)
software using student’s t-test (unpaired) or one-way analysis of
variance (ANOVA) followed by Tukey’s multiple comparison test,
with P < 0.05 considered as statistically significant.
RESULTS
The msaABCR Operon Regulates Energy
Metabolism in S. aureus
Based upon previous work from our laboratory (Sahukhal
et al., 2017), we hypothesized that the deletion of the
msaABCR operon in S. aureus cells would result in increased
metabolic activity, thus inducing a higher energy state that
prevents persister cell formation. To test this prediction,
we first measured the expression of TCA genes and ATP
levels in our test strains (USA300 LAC, MmsaABCR, and
MmsaABCR + pCN34.msaABCR). In S. aureus, the TCA cycle is
activated during late exponential growth phase to generate ATP
when glucose is exhausted (Somerville et al., 2002; Somerville,
2016). We examined TCA cycle activity by measuring the
expression of TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B,
and fumC) in late exponential growth phase via quantitative real-
time PCR (qRT-PCR). As expected, we found transcriptional
upregulation of all the TCA genes in the MmsaABCR compared
with the USA300 LAC strain (Figure 1A). Likewise, the
MmsaABCR exhibited higher ATP levels relative to the USA300
LAC strain in the late stages of exponential growth, including
stationary growth phase (Figures 1B,C). Considering that the
TCA cycle provides reduced dinucleotides, we measured NADH
content in our strains, and the results showed significantly higher
NADH content in the MmsaABCR than in the USA300 LAC
strain (Figure 1D).
Since we observed increased TCA cycle activity and
intracellular ATP level in the MmsaABCR, we hypothesized
that this increased energy level would lead to decreased persister
formation. To test this prediction, we first measured the persister
fraction in late exponential growth phase in the presence
of antibiotics targeting protein synthesis (gentamicin), cell
wall synthesis (vancomycin), and replication (ciprofloxacin).
In this growth phase, the MmsaABCR cells were eradicated
by gentamicin after 24 h, whereas the USA300 LAC and
MmsaABCR + pCN34.msaABCR strains showed prolonged
survival for up to 48 h, with corresponding biphasic killing
curves (Figure 2A). Likewise, the MmsaABCR showed
significantly fewer persister cells than the USA300 LAC
and MmsaABCR + pCN34.msaABCR strains when treated with
vancomycin and ciprofloxacin (Figures 2B,C). Interestingly, all
the test strains showed a higher fraction of persister cells in the
presence of ciprofloxacin than with gentamicin or vancomycin.
Given that the antibiotic tolerance of persister cells is
associated with slow growth (dormancy), our previous study
ruled out the possibility that defective persister cell formation
in the MmsaABCR was influenced by a difference in growth
rate and yield in the stationary phase (Sahukhal et al., 2017). In
our previous study, we observed that the MmsaABCR failed to
form persister cells in stationary growth phase in the presence of
gentamicin. To further examine the specificity of aminoglycoside,
in this study, we measured the persister fraction in the presence
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FIGURE 1 | Measurement of TCA cycle activity, intracellular ATP level, and NAD+/NADH content. (A) Fold change expression of TCA genes (gltA, acnA, icd, sucA,
sucD, sdhA/B, and fumC) in late exponential growth phase for the MmsaABCR compared with the USA300 LAC strain, as measured by qRT-PCR. (B) The ATP
concentrations per CFU of all strains were measured in late exponential and (C) stationary growth phases. The data represent the average of three ATP
concentrations per CFU for each individual sample measured with two biological replicates. (D) Absolute concentration of NAD+/NADH content in all strains grown
to late exponential phase. Error bars represent the standard error of the mean (SEM) for three independent experiments. Statistical significance was determined
using analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *, P ≤ 0.05; **, P ≤ 0.001.
of tobramycin. In both stationary-phase and biofilm growth
conditions, the MmsaABCR formed significantly fewer persister
cells than the USA300 LAC and MmsaABCR+ pCN34.msaABCR
strains (Figures 3A,B). Altogether, these results suggested that
the role of msaABCR in persister formation is specific to
aminoglycoside stress in the stationary growth phase.
Several studies have reported increased persister formation
corresponding to the depletion of ATP in different bacterial
species (Conlon et al., 2016; Shan et al., 2017). These studies,
as well as our observations in late exponential phase, suggest a
causal link between high intracellular ATP content and decreased
persister formation in S. aureus cells. To further examine the
importance of ATP in antibiotic tolerance, we measured the
persister fraction by depleting intracellular ATP with arsenate,
which lowers the rate of ATP synthesis by forming hydrolyzable
ADPs. When cell cultures were pre-exposed to 1 mM arsenate,
the intracellular ATP level was reduced, resulting in a dramatic
increase in the persister level in the MmsaABCR compared with
the USA300 LAC and MmsaABCR + pCN34.msaABCR strains
(Figures 4A,B). These results together demonstrate that a high
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FIGURE 2 | Persister assay in late exponential growth phase. (A–C) The killing
of USA300 LAC, MmsaABCR, and MmsaABCR + pCN34.msaABCR cells in
the presence of antibiotics at the indicated times. All strains were grown in
TSB to late exponential growth phase (OD600 of 4.0) and exposed to
gentamicin (20 × MIC), vancomycin (100 × MIC), or ciprofloxacin
(100 × MIC). (A) Gentamicin treatment. (B) Vancomycin treatment.
(C) Ciprofloxacin treatment. Error bars represent the standard error of the
mean (SEM) from three independent experiments. Statistical significance was
determined using ANOVA followed by Tukey’s multiple comparison tests.
*, P < 0.05; ***, P < 0.0005.
FIGURE 3 | Measurement of persister cells in the presence of aminoglycoside
stress. (A,B) The killing of USA300 LAC, MmsaABCR, and
MmsaABCR + pCN34.msaABCR cells in the presence of tobramycin at the
indicated time points. Strains grown to stationary phase and on biofilms were
exposed to tobramycin (20 × MIC). (A) Tobramycin treatment in
stationary-phase culture. (B) Tobramycin treatment on catheter biofilms. Error
bars indicate SEM of at least three independent experiments. Statistical
significance was determined using ANOVA followed by Tukey’s multiple
comparison tests. **, P < 0.001; ***, P < 0.0005.
cellular energy level is necessary for the killing efficiency of
bactericidal antibiotics and that a low energy level increases
antibiotic tolerance in bacterial cells.
Next, we sought to examine msaABCR regulation of the
TCA cycle. The LysR-type regulator catabolite control protein
(CcpE) functions as a major positive transcriptional regulator
FIGURE 4 | Measurement of ATP level and persister frequency in the
presence of arsenate. (A) ATP concentrations were measured at stationary
growth phase in the presence of 1 mM arsenate. The data represent the
average of three ATP concentrations per CFU of each individual sample
measured with two biological replicates. (B) Persister frequency (log10 survival
fraction) was measured in stationary-phase culture against gentamicin
(20 µg/ml), with and without prior exposure to arsenate. The data represent
the results from three independent experiments. Error bars represent the
SEM. Statistical significance was determined using ANOVA followed by
Tukey’s multiple comparison tests. **, P < 0.001.
of aconitase, encoded by the first gene in the TCA cycle
(acnA) (Hartmann et al., 2013). To delineate the regulatory
role of the msaABCR operon, we measured the expression
of ccpE in late exponential growth phase. qRT-PCR revealed
upregulation of ccpE (>2-fold) in the MmsaABCR compared with
the USA300 LAC strain (Figure 5A). Likewise, in the late stages
of S. aureus growth, catabolism of the amino acid glutamate
by glutamate dehydrogenase (encoded by gudB) ultimately fuels
the TCA cycle through 2-oxoglutarate. Further, to observe the
specific requirement of amino acid catabolism, we measured
the expression of gudB in our test strains grown in chemically
defined media (CDM) containing amino acids. The qRT-PCR
result showed increased expression (>3-fold) of gudB in the
MmsaABCR compared with USA300 LAC strain (Figure 5A).
Further, to examine MsaB regulation of ccpE and gudB, we
performed an EMSA, which showed MsaB binding to the ccpE
promoter (Figure 5B) and thereby suggested that MsaB regulates
the TCA cycle via ccpE. This also confirms our previous finding
of MsaB regulation of ccpE in the UAMS-1 strain (Batte et al.,
2018). However, the absence of binding to the promoter of
gudB suggests that its regulation by MsaB might be indirect
(Figure 5C). All these observations lead us to conclude that MsaB
directly regulates ccpE to control TCA cycle activity and that
the increased energy state in the MmsaABCR led to decreased
persister cell formation in late exponential growth phase.
Decreased Persister Formation in the
Stationary-Phase MmsaABCR Is
Dependent on Increased Membrane
Potential
The activated TCA cycle generates large amounts of
reduced dinucleotides, the oxidation of which requires the
electron transport chain (ETC) (Somerville et al., 2002;
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FIGURE 5 | Measurement of gene expression and electrophoretic mobility shift assay (EMSA). (A) Fold change expression of ccpE in late exponential growth phase
and gudB in the chemically defined medium (CDM) for the MmsaABCR compared with the USA300 LAC strain, as measured by qRT-PCR. (B) MsaB binds to the
ccpE promoter. Increasing concentrations of MsaB–His protein were incubated with a biotin-labeled, 50-bp, dsDNA probe incorporating the promoter region of
ccpE. The band shift is shown in lane 5, while the shift was reversed in a competition assay with a 100-fold greater concentration of unlabeled probe in lane 6.
(C) MsaB does not bind to the promoter of gudB as evidenced by the absence of band shift.
Somerville and Proctor, 2009). The electrons entering into the
ETC from NADH are transferred to menaquinone by the NADH
dehydrogenase complex, and through a series of oxidation
reactions in cytochrome oxidases, finally produces water and
pumps protons (H+) across the membrane to produce pH
and electrochemical gradients or membrane potential (1ψ).
In S. aureus, the NADH dehydrogenase II (SAUSA300_0844,
encoded by ndh2) and cytochrome aa3 oxidase (encoded by
qoxBCD) contribute to the generation of membrane potential
(Clements et al., 1999; Friedrich Götz, 2013; Hammer et al.,
2013; Mayer et al., 2015). Likewise, the F1F0 ATPase (encoded by
atpA) also contributes to the generation of proton-motive force
(PMF) by pumping out protons upon ATP hydrolysis (Grosser
et al., 2018; Wang et al., 2018). In the stationary growth phase,
the TCA cycle is de-repressed when amino acids are catabolized.
Therefore, we measured the relative expression of genes involved
in the ETC, including ndh2, qoxBCD, and atpA, in the test strains
grown in CDM containing amino acids. The qRT-PCR results
showed a significant increase (>2-fold) in expression of the ndh2,
qoxBCD, and atpA genes in the MmsaABCR compared with the
USA300 LAC strain (Figure 6A). A previous study reported that
ndh2 is a major NADH: quinone oxidoreductase, disruption of
which showed a large reduction (70%) in membrane potential
compared with the wild-type USA300 strain (Mayer et al.,
2015). Considering the importance of ndh2 in the generation of
membrane potential, we sought to investigate its regulation by
MsaB. We performed EMSA to examine the binding of MsaB to
the promoter region of ndh2. The result showed MsaB binding
to ssDNA upstream of the transcription initiation site for ndh2
(Figure 6B). However, MsaB did not show binding to the same
region when using dsDNA. This result suggests that MsaB
regulates ndh2, either at the post-transcriptional level or as an
RNA chaperone, as previously reported (Caballero et al., 2018).
Together, these observations suggest that msaABCR (MsaB)
directly regulates NADH oxidation via negative regulation of
ndh2 in the USA300 LAC strain.
Since we observed upregulation of ETC genes in the
MmsaABCR that contribute to membrane potential, we
measured the membrane potential of the mutant via flow
cytometry using the fluorescent membrane stain DiOC2
(3) and compared with the USA300 LAC strain. We also
measured the membrane potential of the ndh2, qoxB, and atpA
mutants. The results showed higher membrane potential in
the MmsaABCR than in the USA300 LAC strain (Figure 7A).
To further confirm the contribution of membrane potential
in persister generation, we measured the persister fraction
in the presence of the proton ionophore carbonyl cyanide
m-chlorophenyl hydrazone (CCCP), a known inhibitor of PMF
generation that dissipates H+ ion gradients. As expected, in
the presence of CCCP (>0.1 µM), the persister fraction in
the MmsaABCR reverted to a level comparable to the USA300
LAC and MmsaABCR + pCN34.msaABCR strains (Figure 7B).
Likewise, CCCP (10 µM) treatment drastically reduced the
membrane potential in both USA300 LAC and MmsaABCR
strains (Figure 7A). The requirement of membrane potential
in persister killing is further supported by the results from the
individual ndh2 and qoxB mutants. The ndh2 and qoxB mutants
showed significantly reduced membrane potential accompanied
by an increased persister fraction relative to the isogenic USA300
LAC strain (Figures 7C,D). The atpA mutant also showed
reduced membraned potential relative to USA300 LAC but was
not statistically significant. Additionally, atpA mutant did show
increased persister fraction and reduced growth rate relative to
the USA300 LAC strains (Figures 7C,D).
It is known that PMF is necessary for aminoglycoside
uptake in bacterial cells, although the complete mechanism
underlying this association is not clear (Taber et al., 1987; Allison
et al., 2011). Aminoglycoside uptake, in turn, is increased with
enhanced membrane potential. Increased membrane potential
as well as increased aminoglycoside killing of the MmsaABCR
then led us to examine gentamicin uptake in our test strains
using the gentamicin: Texas Red conjugate (Gen: TR) method.
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FIGURE 6 | Measurement of electron transport chain (ETC) gene expression and regulation of ndh2. (A) Expression of ETC genes as well as gudB was measured by
qRT-PCR of RNA samples isolated from cells grown overnight in chemically defined medium (CDM). The bar graph shows the fold change in expression of genes in
the MmsaABCR compared with the isogenic USA300 LAC strain. (B) EMSA shows MsaB binding to the promoter of ndh2. Increasing concentrations of MsaB were
incubated with appropriate concentrations of ssDNA from the region upstream of the transcription initiation site for ndh2. The band shift was reduced in a
competition assay with a 100-fold greater concentration of unlabeled ndh2 probe.
Stationary-phase cells were incubated with Gen: TR, and its
uptake was measured by flow cytometry. The results showed
higher gentamicin uptake in the MmsaABCR than in the USA300
LAC strain (Figure 8). Together, these results suggest that
deletion of msaABCR in S. aureus increases the membrane
potential, which causes higher aminoglycoside uptake, leading to
decreased aminoglycoside tolerance.
As we stated above, the stationary-phase MmsaABCR did not
exhibit a low-persister phenotype in response to vancomycin or
ciprofloxacin. Therefore, our observations did not sufficiently
justify the requirement of ATP for antibiotic tolerance in
general, at least in the stationary growth phase. Indeed, a
previous study demonstrated that ATP does not determine
a persister switch in stationary-phase S. aureus cells (Wang
et al., 2018). To further investigate this question, we measured
ATP concentration in the stationary-phase ndh2 mutant, which
showed a similar level of ATP as the isogenic USA300 LAC
strain (Supplementary Figure 1), providing further evidence
that ATP does not play a deterministic role in persister
generation during stationary growth, especially in the presence
of aminoglycoside. Taken together, these observations indicate
that membrane potential is required for the aminoglycoside
killing of persister cells in the stationary growth phase and
that the msaABCR operon negatively regulates the generation of
membrane potential, thereby contributing to S. aureus tolerance
toward aminoglycosides.
Based on the observations reported in this study, we propose a
mechanistic model of msaABCR regulation of TCA cycle activity
and NADH oxidation in USA300 LAC cells (Figure 9). The
msaABCR operon (through MsaB) directly represses ccpE and
indirectly represses gudB to regulate TCA cycle activity and
subsequent intracellular ATP levels in S. aureus cells. In addition,
the msaABCR operon (again through MsaB) directly represses
ndh2, a major NADH: quinone oxidoreductase to regulate the
generation of membrane potential in S. aureus cells.
In conclusion, all the observations reported in this study
lead us to conclude that the deletion of the msaABCR operon
induces a metabolically hyperactive state in S. aureus cells,
as shown by higher TCA cycle activity and higher ATP
content. This increased energy state of the MmsaABCR leads
to decreased persister formation in the presence of different
classes of antibiotics in the late exponential growth phase. In
stationary phase, however, deletion of the msaABCR operon
causes increased membrane potential in S. aureus cells, which
makes a significant contribution to the abrogation of tolerance,
specifically toward aminoglycosides. Together, these results
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FIGURE 7 | Measurements of membrane potential and persister frequency. (A) Stationary-phase cells washed twice with PBS were incubated with 3,
3′-diethyloxacarbocyanine iodide (DiOC2(3)) for 30 min in room temperature. After incubation, the cells were subjected to flow cytometry. The data represents the
ratio between channel F3 (red fluorescence) and F1 (green fluorescence), calculated with FlowJo software. (B) Stationary-phase cells pre-incubated for 30 min with
different concentrations of carbonyl cyanide m-chlorophenyl hydrazone (CCCP) were exposed to gentamicin (20 µg/ml). At 24 h post exposure, the cells were
harvested, washed, and plated for CFU counting. (C) Measurement of membrane potential. (D) Measurement of persister fraction in the mutants of the ETC genes
ndh2, qoxB, and atpA compared with the isogenic USA300 LAC strain in the presence of gentamicin (20 µg/ml). Data represents the log10 survival fraction for the
average of three independent experiments. Error bars represent SEM. Statistical significance was determined using ANOVA followed by Tukey’s multiple comparison
tests. *, P < 0.05; **, P < 0.001.
suggest different mechanisms of regulation of persister formation
by msaABCR that are dependent on the growth phase of
S. aureus cells.
DISCUSSION
Persister cells, being transiently refractory to antibiotics and
able to resuscitate themselves, are strongly associated with
recurrent infections displaying clinical significance. Stationary-
phase S. aureus cells are extremely tolerant to antibiotics,
behaving as persister cells (Conlon et al., 2016). Likewise, a
stationary-phase subpopulation of S. aureus biofilms resembles
persister cells, which are largely responsible for treatment failures.
Indeed, ample evidence suggests the presence of persister cells in
recurrent infections (Conlon, 2014). Therefore, the mechanisms
of persister formation as well as the factors affecting their
survival and eradication are important matters of investigation
that need to be understood to develop effective strategies
to control bacterial infections. Lately, these questions have
received increasing attention; however, investigating the persister
phenotype has been challenging, mostly because of its transience
and rarity in S. aureus populations. Nonetheless, the general
idea about the mechanism of persister formation posits that
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FIGURE 8 | Measurement of gentamicin uptake. The conjugation of gentamicin with Texas Red fluorescence (Gen: TR) in a 30:1 molar ratio was made in anhydrous
N, N-dimethylformamide. The mixture was gently rotated for 3 days at 4◦C. The washed stationary-phase cells were incubated with Gen: TR for 3 h at 37◦C with
continuous shaking. After incubation, the cells were washed twice, resuspended in 500 µl PBS, and evaluated using flow cytometry with excitation/emission maxima
at ∼595/615 nm. The median values for PE-A were measured using FlowJo software. The mean of median values for the three independent experiment were
3589 ± 538 for USA300 LAC and 5356 ± 1021 for the MmsaABCR.
reduced cellular energy promotes tolerance to antibiotics. In
the present study, we attempted to elucidate the msaABCR
regulation of energy metabolism and its association specifically
with aminoglycoside tolerance in stationary-phase S. aureus cells.
The killing efficiency of all the bactericidal antibiotics depends
on the cellular energy level. Therefore, target inactivation due to
a low-energy state should cause increased tolerance to antibiotics
in stationary-phase bacterial cells (Lewis, 2007, 2010). Indeed,
persister cell formation in a growing staphylococcal population
is associated with low cellular energy levels (Conlon et al., 2016;
Shan et al., 2017; Cameron et al., 2018), accompanied by low
levels of expression of TCA enzymes (Zalis et al., 2019). Although
the MmsaABCR exhibited higher ATP levels, the persister fraction
in late exponential phase varied among the antibiotic classes. For
instance, gentamicin eradicated MmsaABCR cells within 48 h.
By contrast, a high persister fraction (∼10%) was observed in
the presence of ciprofloxacin for more than 4 days, whereas a
persister fraction was observed to a lesser extent (∼0.001%) in the
presence of vancomycin. While it is not a unique observation that
the efficiency of bactericidal antibiotics depends on the energy
state of cells, the persister cell phenomenon seems to depend on
how the bacterium responds to a stress in general. In support
of this speculation, a recent study has indeed demonstrated
the formation of intracellular persister cells in response to an
antibiotic stress that also displayed multiple stress responses in
S. aureus (Peyrusson et al., 2020). As we observed a drastic
increase in antibiotic tolerance and reduced intracellular ATP
levels, our findings confirmed that cellular energy is required for
the killing efficiency of bactericidal antibiotics. However, besides
ATP, other factors seem to contribute to antibiotic tolerance.
These factors may vary, depending largely on the growth phase,
which in turn determines whether persister cells are generated or
maintained and whether the cells are active or not. For instance,
due to slow growth, stationary-phase cells exhibit extreme
tolerance to most antibiotics, including vancomycin, which kill
actively growing cells. Since the MmsaABCR has similar growth
and yield as that of the USA300 LAC strain, the killing efficiency
of vancomycin and ciprofloxacin does not appear to be influenced
by ATP concentration, especially in stationary phase. By contrast,
we reasoned that the increased energy state along with the
presence of active targets contributes to increased killing of the
MmsaABCR by bactericidal antibiotics during late exponential
growth phase. It is also possible that deletion of msaABCR
reduces the stochastic events of reduced TCA enzyme expression
during exponential growth phase, resulting in a decreased
persister fraction. On the other hand, the fact that stationary-
phase MmsaABCR cells are eradicated only by aminoglycosides
suggests a different mechanism of persister killing.
Studies have shown a causal link between persister formation
and membrane potential, primarily in the presence of
aminoglycosides. A decreased persister fraction was observed
in response to enhanced membrane potential and subsequently
increased aminoglycoside uptake (Allison et al., 2011; Barraud
et al., 2013; Shan et al., 2015). Likewise, reduced membrane
potential was shown to cause an increased persister fraction in
the TCA mutants of S. aureus (Wang et al., 2018). The small-
colony variants of S. aureus were also found to display increased
resistance toward aminoglycosides due to low membrane
potential (Kriegeskorte et al., 2014). Likewise, disruption
of serine biosynthesis (encoded by serA) with subsequently
increased PMF led to a decreased persister frequency in E. coli
(Shan et al., 2015). A recent study showed increased antibiotic
tolerance associated with reduced ATP and membrane potential
in S. aureus cells in a polymicrobial culture (Nabb et al., 2019).
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FIGURE 9 | Overview of msaABCR (MsaB) regulation of energy metabolism. Inactivation of msaABCR in S. aureus upregulates ccpE, which in turn positively
regulates acnA expression. The consequent increased activation of the TCA cycle results in increased ATP and NADH. Oxidation of NADH, in turn, increases the
membrane potential. MsaB also controls the expression of the ETC gene ndh2 as an RNA chaperone. This process leads subsequently to the biosynthesis of ATP by
the F0F1 ATPase in S. aureus.
Despite a plethora of clues, the complete mechanism linking
persister formation and membrane potential is not understood.
According to our observations, it appears that the
contributions of the energy state and membrane potential
in antibiotic tolerance depend largely on the nature of the
antibiotic stress. Nonetheless, we conclude that deletion of
msaABCR induces S. aureus cells to transition to a higher
energy state, causing decreased persister cell formation during
exponential growth, irrespective of the antibiotics used. Whereas,
due to higher membrane potential, stationary-phase MmsaABCR
cells failed to form persister cells, especially in response to
aminoglycoside antibiotics.
Considering the urgent clinical relevance of persister cells,
understanding the possible mechanisms of their eradication is
highly important in selecting a therapeutic target. S. aureus
systemic infections that are mainly associated with biofilms,
which are difficult to treat. So far, eradication of persisters
by aminoglycosides has been achieved in conjunction with
the metabolites mannitol and fructose, by an ATP-independent
acyldepsipeptide antibiotic (ADEP4), by drugs in combination
with reactive oxygen species, and by membrane disruption-
mediated clearance in different bacterial systems (Allison et al.,
2011; Conlon et al., 2013; Briers et al., 2014; Conlon, 2014; Cui
et al., 2016). However, there has been a lack of clinical efficacy
for these strategies. On the other hand, the use of traditional
antibiotics would be beneficial, considering the requirement of
exhaustive clinical trials for novel therapeutics.
Administration of gentamicin to treat S. aureus infections
is widely used in clinical settings, and evidence confirms
successful treatment of S. aureus systemic and skin infections
with gentamicin without any adverse side effects (Richards et al.,
1971; Chambers and Pallagrosi, 1973; Buabeng et al., 1999;
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Hayward et al., 2018). Similarly, treatment with gentamicin
was shown to control α-toxin production (Worlitzsch et al.,
2001). Likewise, gentamicin was found to shorten treatment
duration when prescribed in combination with daptomycin and
vancomycin (Tsuji and Rybak, 2005). All these results suggest that
gentamicin is a potential antibiotic against S. aureus infections.
However, increased evidence of treatment failures due to the
presence of persister cells warrants identification of the factors
influencing their formation. Our observations further indicate
that msaABCR is a potential target to eradicate S. aureus persister
cells, and it appears that the use of gentamicin in conjunction
with a compound that inhibits msaABCR could be a successful
therapeutic approach to treating recalcitrant S. aureus infections
due to the presence of elusive persister cells.
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